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Introduction
Triclosan (TCS) is a biocide used as an anti-
bacterial and antifungal agent in a number 
of consumer products such as toothpaste, 
mouthwash, disinfectants, and soaps (Dann 
and Hontela 2011). Evidence from in vitro 
and animal studies suggests endocrine-
disrupting properties of TCS including anti-
androgenic activity and disturbance of thyroid 
hormone action (Ahn et al. 2008; Axelstad 
et al. 2013; Gee et al. 2008; Kumar et al. 
2009; Paul et al. 2010, 2012; Veldhoen et al. 
2006). Human exposure to TCS is wide-
spread, and studies in pregnant women have 
found detectable levels of TCS in the vast 
majority of the participants (Casas et al. 2011; 
Philippat et al. 2014; Wolff et al. 2008). 
Moreover, TCS has been detected in amniotic 
fluid, indicating that TCS can enter the 
fetal environment through placental transfer 
(Philippat et al. 2013). Fetal life is considered 
a particularly vulnerable period for exposure 
to endocrine-disrupting chemicals because 
hormonal disturbances during organ devel-
opment may introduce irreversible changes 
(Drake et al. 2009; MacLeod et al. 2010; van 
den Driesche et al. 2011; Welsh et al. 2008). 
However, little is known about the poten-
tial adverse effects of human environmental 
exposure to TCS during fetal life (Wolff 
et al. 2008; Philippat et al. 2012, 2014). A 
statistically nonsignificant inverse association 
between boys prenatally exposed to TCS and 
birth length was reported in a cohort study 
from the United States (Wolff et al. 2008). 
In a French study of 520 male newborns, 
prenatal triclosan exposure was inversely 
associated with prenatal growth  parameters 
measured by ultrasound at approximately 
gestational week 33 and was statistically 
nonsignificantly associated with reduced head 
circumference at birth (Philippat et al. 2014).
Anogenital distance (AGD), the distance 
from the anus to the genitals, is sexually 
dimorphic, with males having a 50–100% 
longer AGD than females (Hsieh et al. 
2008; Salazar-Martinez et al. 2004; Swan 
et al. 2015). In rodents, the AGD has been 
shown to be determined by fetal androgen 
action during early stages of fetal develop-
ment (Welsh et al. 2008). Thus, a reduced 
AGD in males may be indicative of insufficient 
testosterone during the early stages of develop-
ment of male reproductive organs, whereas an 
increased AGD in females suggests excessive 
androgen exposure during the early stages of 
development of female reproductive organs 
(Welsh et al. 2008). In humans, a reduced 
AGD has been observed among boys with the 
genital malformations hypospadias and crypt-
orchidism (Hsieh et al. 2008, 2012; Jain and 
Singal 2013). Moreover, prenatal exposure to 
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Background: Triclosan (TCS) is widely used as an antibacterial agent in consumer products 
such as hand soap and toothpaste, and human exposure is widespread. TCS is suspected of having 
endocrine-disrupting properties, but few human studies have examined the developmental effects of 
prenatal TCS exposure.
oBjectives: We prospectively examined associations between prenatal TCS exposure and anthro-
pometric measures at birth and anogenital distance (AGD) at 3 months of age.
Methods: Pregnant women from the Odense Child Cohort (n = 514) provided urine samples 
at approximately gestational week 28 (median 28.7 weeks, range 26.4–34.0), and urinary TCS 
concentration was measured by isotope dilution TurboFlow–liquid chromatography–tandem mass 
spectrometry. Multiple linear regression analysis was used to examine associations between prenatal 
TCS exposure and measures of size at birth (birth weight, length, head and abdominal circumfer-
ence) and AGD at 3 months of age (median 3.3 months, range 2.3–6.7 months), controlling for 
potential confounders.
results: Newborn boys in the highest quartile of prenatal TCS exposure had a 0.7-cm [95% confi-
dence interval (CI): –1.2, –0.1, p = 0.01] smaller head circumference than boys in the lowest 
quartile. Additionally in boys, inverse associations of borderline statistical significance were 
observed between prenatal TCS exposure and abdominal circumference at birth and AGD at 
3 months of age (p-values < 0.10). Prenatal TCS exposure was not significantly associated with 
any of the outcomes in girls. However, AGD was measured in fewer girls, and we observed no 
significant interactions between a child’s sex and prenatal TCS exposure in anthropometric 
measures at birth.
conclusion: Prenatal TCS exposure was associated with reduced head and abdominal circumfer-
ence at birth and with reduced AGD at 3 months of age in boys, although the last two findings 
were statistically nonsignificant. These findings require replication but are compatible with an 
 anti-androgenic effect of prenatal TCS exposure on fetal growth in boys.
citation: Lassen TH, Frederiksen H, Kyhl HB, Swan SH, Main KM, Andersson AM, Lind DV, 
Husby S, Wohlfahrt-Veje C, Skakkebæk NE, Jensen TK. 2016. Prenatal triclosan exposure and 
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bisphenol A and phthalates has been associated 
with reduced AGD in human male infants 
(Bornehag et al. 2015; Bustamante-Montes 
et al. 2013; Miao et al. 2011; Suzuki et al. 
2012; Swan 2008; Swan et al. 2005, 2015). 
Little is known about the relationship between 
the length of the AGD in females and female 
reproductive system characteristics (Mendiola 
et al. 2012). We have not been able to identify 
any human studies examining associations 
between prenatal exposure to TCS and AGD.
Because very little is known about the 
potential effects of prenatal TCS exposure in 
humans, the aim of our study was to examine 
the associations between maternal urinary 
excretion of TCS as a measure of prenatal 
TCS exposure and birth outcomes as well 
as measurement of AGD at 3 months of age 
stratified by child sex.
Materials and Methods
Study Population
The study was based on data from the Odense 
Child Cohort (Kyhl et al. 2015). Briefly, 
newly pregnant women residing in the 
municipality of Odense, Denmark between 
1 January 2010 and 31 December 2012 
were recruited at gestational age 8–16 weeks 
at a voluntary informational meeting about 
ultrasound examinations, at the first antenatal 
midwife visit, or at the ultrasound examina-
tion at Odense University Hospital. In total, 
6,707 pregnant women were eligible for the 
study, although only 4,017 were informed 
about it. As of November 2014, 2,874 
women (42.9% of the total number eligible) 
were enrolled in the cohort (Kyhl et al. 2015).
While recruitment to the Odense Cohort 
was ongoing, TCS measurements were 
obtained from urine samples collected at 
approximately week 28 of pregnancy (median 
28.7 weeks, range 26.4–34.0) from a subset of 
women with singleton pregnancies (n = 565). 
The subset of women was selected based on 
the availability of urine samples. The first 196 
samples were selected randomly from among 
the women enrolled in the Odense Child 
Cohort between September 2010 and June 
2011, whereas the last 369 samples were 
selected from the remaining women who 
were enrolled by January 2012 who had avail-
able information from questionnaires, urine 
samples, birth records, and clinical examina-
tion of the child at 3 months of age. Of the 
565 women, 51 women were excluded because 
of non-Caucasian origin (n = 30), missing 
information on ethnicity (n = 16), or missing 
data on child sex (n = 5), leaving 514 mother–
child pairs (273 males and 241 females) 
eligible for analyses.
The study was approved by the local ethics 
committee, and the women gave written 
consent to participate in the study. The 
research was conducted in accordance with the 
principles of the Declaration of Helsinki.
Birth Outcomes
From birth records, we obtained information 
about maternal prepregnancy BMI, gesta-
tional age (days) at birth, and birth measures 
such as birth weight (grams), length (centime-
ters), head circumference (centimeters) and 
abdominal circumference (centimeters).
AGD and Penile Measurements
Three months after the expected date of birth, 
regardless of the actual gestational age at 
birth, the children were invited to a clinical 
examination (median age 3.3 months, range 
2.3–6.7 months), which included measure-
ments of length, weight, and AGD. In 
addition, genital malformations were noted. 
Two different measures of AGD were made 
using a Vernier caliper (SPI DigiMax) in 
both boys and girls: In girls, a short AGD 
was measured from the center of the anus 
to the posterior fourchette (AGDaf), and a 
long AGD was measured from the center of 
the anus to the top of the clitoris (AGDac). 
Correspondingly, in boys, a short AGD was 
measured from the center of the anus to the 
posterior base of the scrotum (AGDas), and a 
long AGD was measured from the center of 
the anus to the cephalad insertion of the penis 
(AGDap). Penile width was also measured 
using a Vernier caliper. In each child, the 
genital measures were repeated three times, and 
an arithmetic mean was calculated.
Among the 514 mother–child pairs, 252 
males and 179 females had a minimum of 
one AGD measurement, and 250 males had 
a minimum of one penile measurement at 
the clinical examination at approximately 
3 months of age. AGD measurements were 
initiated in August 2011, but owing to tech-
nical difficulties in measuring AGD in girls, 
these data were valid from October 2011. 
Therefore, data on AGD were available for 
fewer girls than boys. Because children with 
only one or two repeated genital measures 
or who had missing data on the included 
covariates were excluded, n = 245 (AGDas), 
n = 236 (AGDap), n = 241 (penile width), 
n = 178 (AGDaf), and n = 176 (AGDac) were 
included in the statistical analyses.
Four technicians measured AGD in 
both the boys and the girls. The coef-
ficient of variation (CV) was < 10% for all 
the triplicate AGD measurements, except 
for AGDaf, in which two girls had CVs of 
0.10 and 0.14. We conducted subanalyses 
from which those two girls were excluded. 
Additionally, we conducted subanalyses in 
which we also included children who had 
only one or two AGD measurements [n = 1 
(AGDac), n = 1 (AGDas), n = 6 (AGDap), 
n = 3 (penile width)]. For those with two AGD 
measurements, the average was used as the 
outcome measure.
TCS Measurements
At approximately week 28 of gestation, urine 
samples were collected in the morning from 
fasting pregnant women and were subsequently 
stored at ≤ –20°C in freezers at the Odense 
Patient data Explorative Network (OPEN) 
until chemical analyses of total (free and conju-
gated) TCS by isotope dilution TurboFlow–
liquid  chromatography–tandem mass 
spectrometry (LC-MS/MS) with preceding 
enzymatic deconjugation (Frederiksen 
et al. 2013a). Briefly, the 565 samples were 
analyzed in 17 batches. The first 196 samples 
were analyzed between December 2011 and 
January 2012, and the following 369 samples 
were analyzed approximately 1 year later at 
the end of 2012. TCS levels were similar in 
the 2011 and 2012 measurements (p = 0.44, 
assessed by one-way analysis of variance). Each 
batch included standards for calibration curves, 
approximately 35 unknown samples, 2 blanks, 
2 urine pool controls, and 2 urine pool controls 
spiked with TCS standards at low and high 
levels. The interday variation, expressed as the 
relative standard deviation (RSD), was ≤ 14% 
for both spike levels. The recovery of spiked 
samples was > 77%. We used the same control 
materials during both measuring periods, and 
there was no difference in TCS concentration 
in the spiked urine control material. The level 
of detection (LOD) for TCS was 0.06 ng/mL. 
More details on urinary TCS excretion levels 
in the present cohort as well as levels of other 
phenols measured have recently been published 
by Frederiksen et al. (2014).
Urinary osmolality, which is a measure 
of urinary dilution, was measured by the 
freezing point depression method using an 
automatic cryoscopic osmometer (Osmomat® 
030; Gonotec GmbH). For each ninth sample 
measurement, a urine pool was measured as 
a control. The mean urinary osmolality for 
this control pool (n = 77) was 0.825 osmoles/
kilogram (Osm/kg) with a relative standard 
deviation (RSD) of 1.85%. The median (5th, 
95th percentile) osmolality of all urine samples 
included in this study was 0.64 (0.209, 
0.930) Osm/kg.
Statistics
TCS concentrations were adjusted for 
urinary osmolality normalized to the median 
osmolality of all samples (0.64 Osm/kg) to 
correct for dilution of the urine. This adjust-
ment was performed for all samples with a 
measured TCS concentration above the 
LOD by dividing the individual urinary 
TCS concentration (nanograms/milliliter) 
with the individual osmolality of the urine 
sample (osmoles/kilogram) and multiplying 
with the median osmolality of all samples 
Triclosan and anthropometric measures in infants
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(osmoles/kilogram) (Lassen et al. 2013). 
Urinary TCS concentrations below the 
LOD were not adjusted for osmolality but 
were substituted by LOD divided by the 
square root of 2. Osmolality-adjusted TCS 
[nanograms/milliliter(osm)] and the samples 
below the LOD were divided into sex-specific 
quartiles based on the distributions among 
the 273 males and among the 241 females. 
The osmolality-adjusted TCS concentrations 
and the samples below the LOD were also 
entered in the statistical model as a continuous 
variable and were log2-transformed because 
of skewed distribution. The birth outcomes 
(weight, length of the child, head circumfer-
ence, and abdominal circumference), the 
AGD measurements, and the penile width 
were left untransformed because of acceptable 
normal distributions of the residuals.
We calculated the distribution of anthro-
pometric measures at birth and the anogenital 
distance as well as the correlations (Spearman 
correlation coefficients) between the genital 
measures among the boys and among the 
girls. Differences in the distributions of the 
TCS concentrations according to popula-
tion characteristics were assessed by one-way 
analysis of variance. Multiple linear regression 
analysis was used to analyze the associations 
between urinary TCS excretion and birth 
outcomes and AGD measurements adjusted 
for potential confounders. We tested for linear 
trends across TCS quartiles in regression 
models by means of ordinal TCS quartiles 
using integer values from 1 to 4. Confounders 
included in multivariable models were factors 
known a priori to be important predictors 
of birth outcomes or AGD. AGD measure-
ments vary with the age and weight of the 
child, and because the clinical examination 
was scheduled to take place 3 months after 
the expected date of birth, we constructed a 
measure of “post-conceptional age,” which 
we defined as the sum of the gestational age 
at birth (days) and the age of the child at the 
AGD measurements (days). Analyses of asso-
ciations between TCS and AGD were thus 
adjusted for the post-conceptional age and the 
individual weight-for-age standard deviation 
score (SD-score) (Swan 2008) calculated using 
Danish longitudinal growth data (Tinggaard 
et al. 2014). Additionally, to examine whether 
systematic differences in AGD measurements 
between the examiners could confound 
the association between TCS and AGD as 
outcome, we performed sensitivity analyses 
with inclusion of information on the examiner 
as a categorical variable with five categories 
(four different examiners and a category for 
missing information of examiner).
Analyses of associations between TCS 
and infant size at birth (birth weight, birth 
length, head circumference, and abdominal 
circumference) were adjusted for parity 
(primiparous/multiparous), maternal smoking 
during pregnancy (yes/no), prepregnancy BMI 
(< 20, 20–25, > 25 kg/m2) and gestational age 
(days). All results are presented stratified by 
sex given a priori interest in sex differences. 
However, we also tested for potential interac-
tion between child sex and TCS exposure in 
models with birth weight, birth length, head 
circumference, and abdominal circumference 
as outcomes by inserting a product inter action 
term of child sex × maternal urinary TCS 
levels (continuous, osmolality-adjusted, log2-
transformed TCS concentration) in the statis-
tical models. Percentage change in outcomes 
was calculated as the difference between the 
highest exposed group and the reference group 
divided by the intercept × 100, where the 
reference values for the covariates were gesta-
tional age at birth of 280 days, prepregnancy 
BMI between 20 and 25 kg/m2, primiparous, 
and nonsmokers.
There are known ethnic differences in 
size at birth and AGD (Papadopoulou et al. 
2013; Sathyanarayana et al. 2010); therefore, 
we excluded non-Caucasian women to avoid 
confounding because of ethnicity. However, 
we performed sensitivity analyses in which 
we included the non-Caucasian women. We 
also performed sensitivity analyses in which 
maternal height and prepregnancy weight 
were included in the statistical models instead 
of prepregnancy BMI.
Residual plots were used to examine the 
model assumption of homogeneity of vari-
ances, whereas the normality of the distribu-
tion of residuals was examined graphically 
using histograms and normal probability plots 
(data not shown). Associations were consid-
ered statistically significant at the p < 0.05 
level, and observations with missing data for 
variables included in the statistical analyses 
were excluded. We focused on associations 
where we observed trends across quartiles 
because we considered single significant 
observations without a dose–response trend to 
be less reliable.
All data analysis was performed using SAS 
v.9.1 (SAS Institute Inc.).
Results
The mean age at birth among the 514 
women was 31.0 years, 55% of the women 
were primiparous, and 3.6% smoked during 
pregnancy. The mean gestational age at birth 
was 280 days (range 205–296 days) for girls 
and 280 days for boys (range 221–297 days). 
Detectable maternal urinary TCS concentra-
tion was found in 83% of the samples (girls: 
84%, boys: 82%). The median unadjusted 
urinary TCS concentration was 0.88 ng/mL, 
and the 95th percentile and the maximum 
unadjusted TCS concentrat ion were 
428 ng/mL and 2,614 ng/mL, respectively. 
The median (5th, 95th percentile) osmolality-
adjusted TCS concentrations stratified by 
child sex are shown in Table 1. No signifi-
cant associations between maternal osmo-
lality-adjusted TCS levels and population 
characteristics were observed in either girls 
or boys, and maternal osmolality-adjusted 
TCS levels were not significantly different 
between girls and boys. Data on covariates 
were missing for < 2.5% of the observations. 
The 514 women with TCS measurements 
Table 1. Population characteristics according to median (5th, 95th percentile) osmolality-adjusted 
maternal urinary triclosan excretion [nanograms/milliliter(osm)] stratified by child sex among 514 mother–
child pairs.
Population characteristics
Girls Boys
na (%)
Median TCS  
(5th, 95th percentile) 
ng/mL(osm) nb (%)
Median TCS  
(5th, 95th percentile) 
ng/mL(osm)
All 241 (100) 1.01 (< LOD, 536) 273 (100) 0.96 (< LOD, 335)
Maternal age at birth
< 29 years 77 (32) 0.94 (< LOD, 536) 102 (38) 0.76 (< LOD, 210)
29–33 years 82 (34) 0.91 (< LOD, 474) 81 (30) 0.89 (< LOD, 160)
> 33 years 81 (34) 1.43 (< LOD, 562) 84 (31) 1.14 (< LOD, 669)
Prepregnancy BMI (kg/m2)
< 20 22 (9) 1.14 (< LOD, 20) 26 (10) 1.31 (< LOD, 538)
20–25 130 (54) 0.95 (< LOD, 503) 141 (53) 0.93 (< LOD, 182)
25+ 88 (37) 1.07 (< LOD, 719) 100 (37) 0.91 (< LOD, 318)
Parity
Primiparous 124 (51) 1.06 (< LOD, 664) 156 (57) 0.98 (< LOD, 227)
Multiparous 117 (49) 0.95 (< LOD, 503) 116 (43) 0.88 (< LOD, 538)
Maternal smoking during pregnancy
Yes 9 (4) 0.94 (< LOD, 503) 9 (3) 0.31 (< LOD, 1.70)
No 231 (96) 1.06 (< LOD, 546) 258 (97) 0.97 (< LOD, 339)
Preterm birthc 
Yes 8 (3) 1.04 (0.09, 664) 9 (3) 0.82 (< LOD, 23)
No 232 (97) 1.03 (< LOD, 536) 258 (97) 0.95 (< LOD, 339)
Abbreviations: BMI, body mass index; LOD, level of detection; TCS, triclosan.
aBecause of missing data, the numbers do not add up to 241 for the covariates. bBecause of missing data, the numbers 
do not add up to 273 for the covariates. cBirth before gestational week 37.
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eligible for this study did not differ signifi-
cantly from the other singleton birth–giving 
women enrolled in the Odense cohort with 
respect to gestational age at delivery, maternal 
parity, and age (data not shown), whereas 
the mean birth weight among the children 
included in this study was statistically signifi-
cantly higher (3,554 g vs. 3,495 g). There 
were fewer smokers in the present cohort, 
although this difference was not statistically 
significant (3.6% vs. 5.1%).
Mean AGD measures and birth outcomes 
stratified by child sex are shown in Table 2. The 
correlations between the two different AGD 
measures in boys and in girls were r = 0.63 
(p < 0.0001), and r = 0.61 (p < 0.0001), respec-
tively. As expected, the mean AGD measures 
in the boys were nearly twice the corre-
sponding AGD measures in the girls (Table 2). 
Penile width was weakly correlated with 
AGDas (r = 0.22, p = 0.0006) and AGDap 
(r = 0.14, p = 0.03).
Associations Between Maternal 
Urinary TCS Levels and Size at 
Birth
Among the boys, we observed a linear dose-
dependent inverse association between 
maternal urinary TCS levels and head circum-
ference indicated by the trend across TCS 
quartiles (p-trend = 0.01); for every doubling 
in TCS concentration, head circumference 
decreased by 0.06 cm among the boys [95% 
confidence interval (CI): –0.11, –0.002, 
p = 0.04] (Table 3 and Figure 1). When 
maternal urinary TCS levels were catego-
rized in quartiles, boys in the highest TCS 
quartile had, on average, a 0.7-cm (95% CI: 
–1.2, –0.1, p = 0.01) smaller head circum-
ference than boys in the first quartile. This 
difference corresponds to a reduction of 2.0% 
(95% CI: –3.5%, –0.4%) between the fourth 
versus the first exposure quartile. Maternal 
urinary TCS level was also inversely associ-
ated with abdominal circumference among the 
boys in a dose-dependent manner, although 
not statistically significantly (p-trend = 0.07) 
(Table 3 and Figure 1). Boys in the highest 
TCS quartile had, on average, a 0.6-cm 
smaller abdominal circumference than 
boys in the first TCS quartile, although the 
estimate did not reach statistical significance 
(95% CI: –1.2, 0.0, p = 0.07). This differ-
ence corresponds to a reduction in mean 
abdominal circumference of 1.8% (95% CI: 
–3.6%, 0.1%). We observed no significant 
associations between prenatal TCS exposure 
and birth weight [e.g., for boys in the highest 
vs. lowest exposure quartile, β = –81 g 
(95% CI: –218, 56, p = 0.25)], and there was 
no consistent trend in estimated associations 
with increasing exposure. We observed a signif-
icant positive association between birth length 
and the third versus the first quartile of TCS, 
but in the other quartiles, the β values were 
close to null and without a consistent pattern 
according to prenatal TCS exposure (Table 3 
and Figure 1).
We found no significant associations 
or consistent dose–response relationships 
between prenatal TCS exposure and any of 
the measures of size at birth in girls (Table 3 
and Figure 1).
The interaction terms between child sex 
and prenatal TCS exposure in models with 
birth weight, birth length, head circum-
ference, and abdominal circumference as 
outcomes were not statistically significant 
(Table 3), but the population size (i.e., the 
statistical power) was likely too small to test 
for interaction.
Associations Between Maternal 
Urinary TCS Levels and AGD at 
3 Months of Age
In the boys, inverse associations between 
maternal urinary TCS levels and both the long 
and the short AGD measures were observed, 
although the estimates did not reach statistical 
significance (p-values < 0.10): every doubling 
in TCS concentration was associated with 
a decrease of 0.2 mm (95% CI: –0.3, 0.0, 
p = 0.08) in AGDas and a decrease of 0.2 mm 
(95% CI: –0.4, 0.0, p = 0.05) in AGDap 
(Table 4). Penile width was not associated 
with maternal urinary TCS levels.
We observed no significant associations or 
consistent dose–response associations between 
prenatal TCS exposure and anogenital 
distance in the girls (although our calculations 
were based on fewer observations than in the 
boys) (Table 4).
Subanalyses showed that inclusion of 
children with only one or two of the three 
AGD measurements did not appreciably 
change the results (< 10% change in esti-
mates; results not shown); nor did inclu-
sion of examiner information, inclusion 
of non-Caucasian women, or inclusion of 
maternal height and prepregnancy weight 
instead of prepregnancy BMI in the analyses 
substantially change the observed associations 
(results not shown).
Discussion
In this prospective study, we observed an 
inverse association between prenatal TCS 
exposure as measured by maternal urinary 
TCS excretion and head circumference in 
newborn boys. There were no clear associa-
tions between prenatal TCS exposure and 
birth weight or birth length in boys. We also 
observed reduced abdominal circumference 
and shorter AGD in boys born to mothers 
with higher urinary TCS levels, although 
these estimates did not reach statistical signifi-
cance (p < 0.10). In contrast, we observed 
no significant associations between prenatal 
TCS exposure and any of the outcomes in 
girls. However, AGD was measured in fewer 
girls. Analyses of interactions between sex and 
prenatal TCS exposure were not statistically 
significant, which was likely because of small 
sample size and therefore low statistical power 
to perform interaction analyses.
The observed reduction of 0.7 cm in 
head circumference in boys between the 
highest versus the lowest exposed quartile 
was of similar magnitude to the differences 
in head circumference between boys and 
girls that were observed in this study (mean 
difference = 0.6 cm) as well as having been 
reported at birth in other studies (Greil 
2006; Sankilampi et al. 2013). For example, 
in a Finnish register-based study based on 
533,666 singletons born between 1996 and 
2008, girls born at 40 weeks of gestation had 
on average a 0.65-cm smaller head circumfer-
ence than boys born at the same gestational 
age (Sankilampi et al. 2013).
Few human studies have examined 
prenatal TCS exposure and birth outcomes, 
and to our knowledge, no human study has 
examined associations with AGD. Consistent 
with the findings of the present study, a 
French mother–child cohort study including 
520 newborn boys observed a statistically 
nonsignificant inverse association between 
prenatal triclosan exposure and head circum-
ference, but no associations with length or 
weight at birth were observed (Philippat et al. 
2014). In a cohort study from the United 
States that included 339 mothers and their 
offspring, Wolff et al. (2008) reported a 
statistically nonsignificant inverse association 
between prenatal TCS exposure and birth 
Table 2. Distribution (mean, ± standard deviation) of anthropometric measures at birth and  anogenital 
distance at approximately 3 months of age among boys and girls from the Odense Child Cohort.
Anthropometric and AGD measures
Girls Boys
n Mean SD n Mean SD
Birth weight (g) 240 3,502 503 267 3,600 536
Birth length (cm) 239 51.8 2.2 264 52.4 2.4
Head circumference (cm) 238 34.9 1.7 264 35.5 1.8
Abdominal circumference (cm) 237 33.5 2.3 261 33.7 2.1
AGD, short (mm) 179 20.1 3.6 251 36.8 5.5
AGD, long (mm) 177 37.7 4.4 242 70.7 6.5
Penile width (mm) — — — 247 13.8 1.2
Abbreviations: AGD, anogenital distance; SD, standard deviation.
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Table 3. Associations between maternal pregnancy triclosan levels and birth outcomes among newborn boys and girls from the Odense Child Cohort.
TCS 
Birth weight (g) Birth length (cm) Head circumference (cm) Abdominal circumference (cm)
n β (95% CI) p-Value n β (95% CI) p-Value n β (95% CI) p-Value n β (95% CI) p-Value
Boys
TCS quartilea
1st 69 Reference 69 Reference 69 Reference 68 Reference
2nd 66 –62 (–199, 74) 0.37 66 0.1 (–0.5, 0.7) 0.83 66 –0.2 (–0.7, 0.4) 0.52 64 –0.3 (–0.9, 0.3) 0.33
3rd 66 29 (–108, 166) 0.68 65 0.7 (0.1, 1.3) 0.03 64 –0.3 (–0.9, 0.2) 0.24 64 –0.4 (–1.0, 0.2) 0.22
4th 66 –81 (–218, 56) 0.25 64 0.1 (–0.5, 0.8) 0.65 65 –0.7 (–1.2, –0.1) 0.01 65 –0.6 (–1.2, 0.0) 0.07
p-Trendb 0.49 0.29  0.01 0.07
Continuousc 267 –5.2 (–18.5, 8.2) 0.45 264 0.01 (–0.05, 0.07) 0.70 264 –0.06 (–0.11, –0.002) 0.04 261 –0.05 (–0.11, 0.01) 0.09
Girls
TCS quartilea
1st 60 Reference 59 Reference 59 Reference 59
2nd 60 50 (–90, 190) 0.48 60 –0.5 (–1.1, 0.1) 0.11 60 –0.4 (–0.9, 0.2) 0.19 60 0.3 (–0.4, 0.9) 0.47
3rd 60 25 (–116, 167) 0.72 60 –0.4 (–1.0, 0.2) 0.24 60 –0.3 (–0.8, 0.2) 0.28 59 0.1 (–0.6, 0.8) 0.84
4th 60 36 (–104, 176) 0.62 60 –0.2 (–0.8, 0.4) 0.53 59 –0.2 (–0.7, 0.3) 0.49 59 –0.03 (–0.7, 0.6) 0.93
p-Trendb 0.71 0.66 0.56 0.81
Continuousc 240 4.7 (–7.3, 17.0) 0.43 239 –0.004 (–0.06, 0.05) 0.89 238 –0.01 (–0.05, 0.04) 0.70 237 0.00 (–0.06, 0.06) 0.998
TCS × Sex
p-Interactiond 507 0.39 503 0.57 502 0.24 498 0.27
Abbreviations: CI, confidence interval; LOD, level of detection; TCS, triclosan.
All estimates are adjusted for gestational age, maternal smoking, parity and prepregnancy BMI. aMedian (range) for osmolality-adjusted TCS quartiles [nanograms/milliliter(osm)] in 
boys: 1st = < LOD (< LOD to < 0.24), 2nd = 0.53 (0.24 to < 0.97), 3rd = 1.69 (0.97 to < 3.24), 4th = 17.8 (3.24 to 1,702); in girls: 1st = < LOD (< LOD to < 0.247), 2nd = 0.50 (0.247 to < 1.05), 3rd = 
2.03 (1.05 to < 4.21), 4th = 103.1 (4.21 to 2,350). bp-Value for trend across TCS quartiles. clog2-transformed TCS concentration. dp-Value for interaction [child sex × maternal urinary TCS 
levels (continuous log2-transformed TCS concentration)]. Median gestational week of maternal urine collection for boys: 28.7 (26.4–30.4) weeks; for girls: 28.7 (range 27.9–34.0) weeks.
Figure 1. Differences (β-coefficients from multiple linear regression) and 95% confidence intervals (CIs) in anthropometric measures at birth among newborn 
boys and girls from the Odense Child Cohort in relation to prenatal triclosan (TCS) exposure quartiles [nanograms/milliliter(osm)]. All estimates are adjusted for 
gestational age, maternal smoking, parity, and prepregnancy body mass index (BMI). Median (range) for osmolality-adjusted TCS quartiles (ng/mLosm) in boys: 1st 
= < level of detection (LOD) (< LOD–< 0.24), 2nd = 0.53 (0.24–< 0.97), 3rd = 1.69 (0.97–< 3.24), 4th = 17.8 (3.24–1,702); in girls: 1st = < LOD (< LOD–< 0.247), 2nd = 0.50 
(0.247–< 1.05), 3rd = 2.03 (1.05–< 4.21), 4th = 103.1 (4.21–2,350). 
p-Trend: p-value for trend across TCS quartiles.
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length among boys. Consistent with the 
findings of the present study, Wolff et al. did 
not observe any associations between prenatal 
TCS exposure and birth outcomes among girls 
(Wolff et al. 2008). Notably, both of these 
earlier studies reported considerably higher 
median maternal urinary TCS concentrations 
[Wolff et al. (2008): 11 ng/mL; Philippat 
et al. (2014): 30 ng/mL] than those reported 
in our study (0.88 ng/mL). However, the 
variation in TCS levels in the present study 
was large (5th, 95th percentile and maximum: 
< LOD, 428, and 2,614 ng/mL, respectively), 
suggesting that some pregnant Danish women 
were as highly exposed as women in previous 
studies [Wolff et al. (2008): maximum TCS 
concentration, 1,790 ng/mL; Philippat et al. 
(2014): 95th percentile TCS concentra-
tion, 755 ng/mL]. The differences in overall 
urinary TCS excretion across studies may 
reflect differences in consumer behavior 
between countries.
Studies in rats have shown no effects of 
prenatal TCS exposure on size at birth or 
on AGD (Axelstad et al. 2013; Rodríguez 
and Sanchez 2010). However, reproductive 
effects, including reduced levels of follicle-
stimulating hormone (FSH), luteinizing 
hormone (LH), and testosterone, have been 
shown in adult male rats exposed to 20 mg/kg 
bw/day TCS for a period of 60 days (Kumar 
et al. 2009), and reduced sperm produc-
tion was observed in rats exposed to 50 
and 200 mg/kg TCS for 8 weeks (Lan 
et al. 2013). These findings suggest that the 
 hypothalamic– pituitary–gonadal axis may be 
affected by TCS exposure. Furthermore, in 
a number of rat studies, TCS exposure has 
consistently been shown to induce hypothy-
roxinemia in dams exposed during gestation 
and lactation (Axelstad et al. 2013; Paul et al. 
2010, 2012) and in neonate pups exposed 
prenatally (Paul et al. 2010, 2012). These 
findings suggest that TCS may have thyroid 
hormone–disrupting effects. Additionally, 
in vitro studies have suggested different modes 
of action for TCS, including estrogenic, 
androgenic, anti-androgenic and gestagenic 
effects (Ahn et al. 2008; Christen et al. 2010; 
Gee et al. 2008; Schiffer et al. 2014).
This study was not designed to elucidate 
mechanisms of action. However, because we 
observed associations between prenatal TCS 
exposure and measures of growth only among 
the boys (although the results of interaction 
analyses were nonsignificant), and because 
the difference in mean head circumference 
between boys with the highest versus the 
lowest TCS exposure was comparable to the 
average difference in head circumference 
between boys and girls reported for other 
populations (Sankilampi et al. 2013), we 
speculate that our findings may be compat-
ible with an anti-androgenic mechanism of 
action of TCS. Nevertheless, other mecha-
nisms of action of TCS leading to diminished 
growth are also possible, such as a perturba-
tion of the thyroid axis. These results need to 
be confirmed in future studies, ideally with 
measurement of hormone levels. A causal 
relationship between prenatal TCS exposure 
and reduced head circumference would be 
of considerable public health significance 
because reduced head circumference at birth 
has been associated with impaired cognitive 
performance (Lundgren et al. 2001; Veena 
et al. 2010).
A reduced AGD in males may be a 
marker of testicular dysgenesis syndrome 
(TDS) (Juul et al. 2014; Thankamony et al. 
2014), suggesting that some male reproduc-
tive disorders may be symptoms of a common 
underlying fetal testicular dysgenesis, which 
may be caused by a disturbance in Sertoli cell 
and Leydig cell differentiation during fetal life 
leading to impaired testosterone production 
(Skakkebæk et al. 2001). Based on results 
from animal studies, shortening of the AGD 
in newborn males is attributed to impaired 
androgen action during a particularly sensi-
tive developmental window, which is believed 
to correspond to gestational weeks 8 to 14 
in humans (Welsh et al. 2008). The observa-
tion in this study of reduced AGD in boys, 
although statistically nonsignificant, is there-
fore consistent with an anti-androgenic effect 
of TCS on the fetus. This finding is also in 
accord with in vitro studies showing anti-
androgenic action of TCS (Ahn et al. 2008; 
Gee et al. 2008), although a study examining 
developmental effects following in utero TCS 
exposure in rats did not show significant 
changes in AGD in male offspring (Axelstad 
et al. 2013), and no association was observed 
between prenatal triclosan exposure and unde-
scended testis in a rather small study of 151 
male newborns (Chevrier et al. 2012).
TCS is quickly metabolized with a urinary 
excretion half-life of < 24 hr (Sandborgh-
Englund et al. 2006). A single spot urine 
sample collected in approximately gestational 
week 28 may therefore potentially fail to accu-
rately reflect average fetal exposure during the 
entire pregnancy or during the developmental 
window early in fetal life that is suggested to be 
particularly sensitive for the formation of the 
AGD (Welsh et al. 2008). However, studies 
of temporal variability in urinary excretion 
of TCS have indicated reasonable temporal 
consistency in TCS excretion (Lassen et al. 
2013; Meeker et al. 2013; Philippat et al. 
2013), with interclass correlation coefficients 
among pregnant women between 0.47 and 
0.58 (Meeker et al. 2013; Philippat et al. 2013) 
suggesting relatively stable exposure sources to 
TCS throughout gestation. Nevertheless, some 
exposure misclassification is to be expected 
when using a single urine sample collected 
during pregnancy for exposure classification. 
Such misclassification may lead to underes-
timation of an association between prenatal 
TCS exposure and AGD. The third trimester 
of pregnancy is characterized by rapid fetal 
weight gain, and urine samples collected in 
approximately the 28th week of gestation 
may therefore characterize a relevant window 
of exposure for fetal growth effects. In this 
study, AGD was measured at approximately 
3 months of age. In a study by Thankamony 
et al. (2009), AGD measurements at 3 months 
of age have been shown to be weakly, though 
significantly, correlated with AGD measure-
ments at birth in both boys (r = 0.30) and 
girls (r = 0.26).
Table 4. Associations between maternal pregnancy TCS levels and AGDas (short AGD measure), AGDap (long AGD measure) and penile width in boys and 
AGDaf (short AGD measure) and AGDac (long AGD measure) in girls at 3 months of age from the Odense Child Cohort.
TCS quartilea
Boys Girls
AGDas (mm) AGDap (mm) Penile width (mm) AGDaf (mm) AGDac (mm)
n β (95% CI) p-Value n β (95% CI) p-Value n β (95% CI) p-Value n β (95% CI) p-Value n β (95% CI) p-Value
1st 64 Reference 63 Reference 63 Reference 51 Reference 50 Reference
2nd 61 –0.9 (–2.8, 0.9) 0.33 60 0.3 (–1.7, 2.3) 0.77 59 0.0 (–0.4, 0.5) 0.81 40 –0.5 (–2.0, 1.0) 0.51 40 –0.6 (–2.4, 1.2) 0.54
3rd 62 –2.3 (–4.1, –0.4) 0.02 59 –1.2 (–3.3, 0.8) 0.24 62 –0.1 (–0.5, 0.3) 0.55 43 –0.4 (–1.8, 1.1) 0.59 43 0.1 (–1.6, 1.9) 0.87
4th 58 –1.3 (–3.1, 0.6) 0.19 54 –1.3 (–3.4, 0.8) 0.22 57 –0.2 (–0.6, 0.3) 0.44 44 –0.3 (–1.8, 1.1) 0.66 43 0.1 (–1.7, 1.8) 0.95
p-Trendb 0.08 0.11 0.32 0.69 0.79
Continuousc 245 –0.16 (–0.34, 0.02) 0.07 236 –0.20 (–0.39, 0.00) 0.05 241 –0.02 (–0.06, 0.02) 0.27 178 –0.02 (–0.15, 0.10) 0.72 176 0.01 (–0.15, 0.17) 0.89
Abbreviations: AGD, anogenital distance; AGDac, long AGD measure (girls); AGDaf, short AGD measure (girls); AGDap, long AGD measure (boys); AGDas, short AGD measure (boys); CI, confidence 
interval; TCS, triclosan.
All estimates are adjusted for weight for age standard deviation score and post-conceptional age (gestational age at birth + age of the child at the AGD measurements, days). aMedian (range) for 
osmolality-adjusted TCS quartiles [nanograms/milliliter(osm)] in boys: 1st = < LOD (< LOD to < 0.24), 2nd = 0.53 (0.24 to < 0.97), 3rd = 1.69 (0.97 to < 3.24), 4th = 17.8 (3.24 to 1,702); in girls: 1st = < LOD 
(< LOD to < 0.247), 2nd = 0.50 (0.247 to < 1.05), 3rd = 2.03 (1.05 to < 4.21), 4th = 103.1 (4.21 to 2,350). bp-Value for trend across TCS quartiles. cLog2-transformed TCS concentration. Median age at AGD 
measurements for boys, 3.3 months (range 2.3–6.2 months); for girls, 3.3 months (range 2.3–6.7 months).
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In this study, a relatively large number 
of statistical analyses were performed, and 
some of our results may be chance findings 
resulting from multiple testing. We had a 
relatively limited sample size and, hence, 
limited statistical power for analyses of sex-
specific associations between TCS exposure 
and growth measures. The suggested sex-
specific differences in outcomes are therefore 
hypothetical and should be confirmed in 
other studies.
It is possible that selection bias affected 
the results. Only 43% of the eligible women 
participated, and participants were more often 
of Danish origin and were better educated 
than nonparticipants. The women included in 
this study had a lower prevalence of smoking 
during pregnancy (~4%) than nonpartici-
pants (12%), who were women giving birth 
between 2010 and 2013 and living in the 
recruitment area of the Odense Child Cohort 
(Kyhl et al. 2015). The mean age at delivery 
in our study was, however, identical to the 
mean age of all Danish women giving birth 
in Denmark in 2011 (Danish Health and 
Medicines Authority 2012), and the median 
TCS concentration among the pregnant 
women in this study was comparable with 
levels observed in Danish children 6–11 years 
of age and in their mothers from samples 
collected in 2011 (median 0.46 ng/mL 
and 0.64 ng/mL, respectively) (Frederiksen 
et al. 2013b). The women in this study had 
no prior knowledge of their TCS exposure, 
which therefore is unlikely to have affected 
their willingness to participate. Although all 
estimates of associations were adjusted for 
relevant confounders, we cannot exclude the 
possibility of confounding by other factors 
associated with TCS and growth measures, 
such as co-exposure to other environmental 
chemicals or lifestyle factors. Therefore, our 
findings need to be confirmed in additional 
human studies.
Conclusions
Prenatal TCS exposure was associated with 
reduced head circumference and abdominal 
circumference at birth and with a reduced 
AGD at 3 months of age in boys, although 
the last two findings did not reach statis-
tical significance (p < 0.10). No associations 
between prenatal TCS exposure and birth 
outcomes and AGD were found in girls, 
although AGD was measured for fewer girls 
and the interactions between child sex and 
TCS were not statistically significant. Because 
of the suggestive sex differences, we speculate 
that our findings are compatible with an anti-
androgenic effect of prenatal TCS exposure 
on fetal development in boys. However, our 
findings need to be confirmed in other popu-
lations, and the biological mechanisms should 
be elucidated.
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